期刊文献+

失眠对老年高血压患者心率变异性的影响 被引量:14

Effects of insomnia on heart rate variability in the elderly with hypertension
原文传递
导出
摘要 目的探讨失眠对老年高血压患者心率变异性(HRV)的影响。方法入选老年患者259例,分为健康对照组74例、单纯高血压组71例、高血压并存失眠组114例,其中高血压并存失眠组按失眠病程分为〈5年、5~9年和≥10年。进行24h动态心电图检查,收集其HRV时域指标(SDNN、SDANN和ASDNN)进行对比分析。结果与健康对照组相比,单纯高血压组和高血压并存失眠组HRV各时域指标降低(F=12.02,10.54和4.27,P%0.01);与单纯高血压组相比,高血压并存失眠组HRV各时域指标降低(P〈0.01)。高血压并存失眠组中失眠5~9年和≥10年组的SDNN和SDANN均较失眠〈5年降低(F=8.63和4.54,P〈0.01);失眠≥10年的SDNN较5~9年进一步降低,差异具有统计学意义(P〈O.01)。结论失眠可加重高血压患者自主神经功能紊乱,失眠年限延长,高血压患者自主神经功能紊乱程度增加。 Objective To explore the effects of insomnia on heart rate variety(HRV) in aged hypertension patients. Methods 259 subjects were divided into healthy group (74 cases), simple hypertension group (71 cases), coexisting hypertension and insomnia group (114 cases) which was sub-grouped to 〈5 years, 5 9 years and ≥10 years according to the duration of insomnia. All subjects had 24 h recordings of ECG. The data of HRV time domain (SDNN, SDANN and ASDNN) were collected and compared. Results HRV time domain was lower in healthy group than in the other two groups (F=12,02, 10.54 and 4.27, P〈0. O1), and decreased more significantly in coexisting hypertension and insomnia group compared with simple hypertension group(P〈0.01). The values of SDNN and SDANN in 5 9 years and ≥10 years subgroups decreased as compared with 〈5 years subgroup (F=8.63 and 4.54, P〈0.01), and these values further lower in ≥10 years subgroup than in 5-9 years subgroup (P〈0. 01). Conclusions Insomnia may lead to more serious disorder of automatic nervous system and further aggravated disorders appear in the elderly with hypertension along with increasing years of insomnia.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第1期51-53,共3页 Chinese Journal of Geriatrics
关键词 入睡和睡眠障碍 高血压 心率 Sleep initiation and maintenance disorders Hypertension Heart rate
  • 相关文献

参考文献6

二级参考文献41

  • 1盛勇,蔡力,张廷杰.从JNC7和2003欧洲指南看药物经济学在高血压防治中的作用[J].心血管病学进展,2005,26(2):107-108. 被引量:9
  • 2沈文锦.心率变异性检测及其临床应用(一)[J].心功能杂志,1995,7(3):166-170. 被引量:24
  • 3<血管紧张素转换酶抑制剂在肾脏病中正确应用>专家协会组.血管紧张素转换酶抑制剂在肾脏病中正确应用的专家共识[J].中华肾脏病杂志,2006,22(1):57-58. 被引量:69
  • 4中国高血压防治指南修订委员会.中国高血压防治指南2005年修订版.北京:中国高血压防治指南修订委员会,2005.
  • 5Beekett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N EnglJ Med,2008,358:1887-1898.
  • 6Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med,2006,354:131-140.
  • 7Hou FF, Xie D, Zhang X, et al. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol, 2007,18 : 1889-1898.
  • 8ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT). JAMA, 2002,288 : 2998-3007.
  • 9Bakris GL, Copley JB, Vicknair N, et al. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int, 1996,50 : 1641-1650.
  • 10Wright JT Jr,Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA, 2002, 288: 2421-2431.

共引文献816

同被引文献131

引证文献14

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部